MedPath
HSA Approval

EMENAT TABLETS 1 MG

SIN15174P

EMENAT TABLETS 1 MG

EMENAT TABLETS 1 MG

February 9, 2017

NATCO PHARMA ASIA PTE. LTD.

NATCO PHARMA ASIA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNATCO PHARMA ASIA PTE. LTD.
Licence HolderNATCO PHARMA ASIA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A04AA02

granisetron

Manufacturer Information

NATCO PHARMA ASIA PTE. LTD.

Natco Pharma Limited-Pharma Division

Active Ingredients

Granisetron Hydrochloride 1.120mg eqv Granisetron

1.0 mg

Granisetron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EMENAT TABLETS 1 MG - HSA Approval | MedPath